Medicamen Biotech Limited (BOM:531146)
India · Delayed Price · Currency is INR 292.55
+12.45 (4.44%)
At close: May 6, 2026
Medicamen Biotech Market Cap
Medicamen Biotech has a market cap or net worth of 3.72 billion as of May 6, 2026. Its market cap has decreased by -40.78% in one year.
Market Cap
3.72B
Enterprise Value
3.67B
Revenue
1.72B
Ranking
n/a
PE Ratio
50.07
Stock Price
292.55
Market Cap Chart
Since January 12, 2005, Medicamen Biotech's market cap has increased from 108.49M to 3.72B, an increase of 3,328.61%. That is a compound annual growth rate of 18.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 3.72B | -19.42% |
| Dec 31, 2025 | 4.62B | -28.94% |
| Dec 31, 2024 | 6.50B | -14.77% |
| Dec 29, 2023 | 7.62B | -27.09% |
| Dec 30, 2022 | 10.45B | -3.50% |
| Dec 31, 2021 | 10.83B | 86.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jenburkt Pharmaceuticals | 4.61B |
| Amanta Healthcare | 4.50B |
| Albert David | 4.11B |
| Medico Remedies | 3.53B |
| Sat Kartar Life | 3.08B |
| Trident Lifeline | 2.98B |
| Speciality Medicines | 2.90B |
| Kerala Ayurveda | 2.82B |